• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.09% Nasdaq Up 0.41%

    Repligen Corporation (RGEN)

    -NasdaqGS
    24.07 Up 0.40(1.69%) 1:47PM EDT - Nasdaq Real Time Price
    Prev Close:23.67
    Open:23.61
    Bid:24.02 x 100
    Ask:24.07 x 200
    1y Target Est:31.75
    Beta:1.15959
    Earnings Date:Aug 4 - Aug 8 (Est.)
    Day's Range:23.33 - 24.19
    52wk Range:20.07 - 42.48
    Volume:64,010
    Avg Vol (3m):315,219
    Market Cap:809.68M
    P/E (ttm):100.29
    EPS (ttm):0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for RGEN

    Comparison

    Symbol% ChgMkt Cap
    RGENUp 1.69%809.68M
    BIOUp 0.16%4.35B

    Key Statistics

    Forward P/E (1 yr):39.44
    P/S (ttm):9.07
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :0.47
    Quarterly EPS Est (Jun-16) :0.13
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):2.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Repligen Corporation, a bioprocessing company, focuses on the development, production, and commercialization of products used in the production of monoclonal antibodies, recombinant proteins, and vaccines. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback